Cisco Systems, Inc. $CSCO Shares Sold by Boston Research & Management Inc.

Institutional flows in Cisco (CSCO) are notable: Boston Research & Management slightly trimmed its stake to 144,750 shares (~$10.0M), while large managers — Franklin Resources, Goldman Sachs, Kingstone Capital, Nuveen and Acadian — added substantial new or increased positions, leaving roughly 73.3% of the stock in institutional hands. The shares are trading around $76 (up ~0.9%), market cap ~$300.7B, P/E 29.1 and PEG 3.0; the company announced a $0.41 quarterly dividend (2.2% yield, DPR ~61.7%) and analysts have been lifting targets and ratings (several to Buy and targets up to $100, consensus target ~$84.14). However, insiders have sold about 1.02M shares (~$79.1M) in the past 90 days and insiders now hold only 0.01%, so while the analyst momentum and heavy institutional buying point to potential upside, valuation and notable insider selling introduce a degree of caution.

Analysis

Boston Research & Management marginally trimmed its CSCO stake by 0.8% to 144,750 shares after selling 1,133 shares in Q2, while several large managers materially increased or initiated positions — Franklin Resources added 12,904,969 shares to reach 40,836,858 shares ($2.833B), Goldman Sachs added 12,775,066 shares to reach 46,973,293 shares ($2.899B), Kingstone initiated a ~$904.5M stake, Nuveen initiated a ~$750.5M position, and Acadian boosted to 7,819,547 shares after a 255.9% increase; institutional ownership stands at 73.33%. Shares opened at $76.10, trading above the 50-day ($70.84) and 200-day ($68.13) SMAs, with a market cap of $300.68B, P/E of 29.05, PEG of 3.00, beta 0.95 and a 12-month range of $52.11–$80.06. Cisco declared a $0.41 quarterly dividend (annualized $1.64, 2.2% yield, DPR 61.65%, ex-dividend Jan 2), and analysts have raised targets and ratings (17 Buys, 9 Holds) producing a consensus target of $84.14. Insiders sold 1,017,988 shares worth ~$79.09M in the last 90 days and now hold 0.01%, which contrasts with heavy institutional accumulation; together this suggests positive analyst/institutional momentum but signals to monitor valuation and insider conviction closely.

Key Decisions for Investors

• Consider adding exposure or overweight modestly given heavy institutional buying and analyst upgrades with a consensus target of $84.14 (implying ~10% upside from the $76 level),
• Use pullbacks toward the 50-day ($70.84) or 200-day ($68.13) SMAs as tactical entry points rather than chasing at highs,
• Limit position size or hedge exposure because valuation (P/E 29, PEG 3) is elevated and notable insider selling (1.02M shares in 90 days, insiders now 0.01%) reduces conviction,
• For income-oriented allocations, treat the 2.2% yield as supplementary income given a DPR of ~61.65% and monitor cash flow/dividend announcements around the Jan ex-dividend date